These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8686526)

  • 1. CSF neurotransmitter metabolites in comatose head injury patients during changes in their clinical state.
    Markianos M; Seretis A; Kotsou A; Christopoulos M
    Acta Neurochir (Wien); 1996; 138(1):57-9. PubMed ID: 8686526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF neurotransmitter metabolites and short-term outcome of patients in coma after head injury.
    Markianos M; Seretis A; Kotsou S; Baltas I; Sacharogiannis H
    Acta Neurol Scand; 1992 Aug; 86(2):190-3. PubMed ID: 1384260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amine metabolites in ventricular cerebrospinal fluid in coma.
    Yates CM; Tsementzis SA; Wilson H
    J Neurol Neurosurg Psychiatry; 1979 Oct; 42(10):887-91. PubMed ID: 512664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homovanillic acid and 5-hydroxyindole-acetic acid in the csf of patients after a severe head injury. I. Lumbar csf concentration in chronic brain post-traumatic syndromes.
    Bareggi SR; Porta M; Selenati A; Assael BM; Calderini G; Collice M; Rossanda M; Morselli PL
    Eur Neurol; 1975; 13(6):528-44. PubMed ID: 1193100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid levels of monoamine metabolites in panic disorder.
    Eriksson E; Westberg P; Alling C; Thuresson K; Modigh K
    Psychiatry Res; 1991 Mar; 36(3):243-51. PubMed ID: 1712114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homovanillic acid and 5-hydroxyindole-acetic acid in the csf of patients after a severe head injury. II. Ventricular csf concentrations in acute brain post-traumatic syndromes.
    Porta M; Bareggi SR; Collice M; Assael BM; Selenati A; Calderini G; Rossanda M; Morselli PL
    Eur Neurol; 1975; 13(6):545-54. PubMed ID: 1193101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biogenic amine metabolites in human CSF after hypoxia due to cardiac arrest.
    Odink J; Kärkelä J; Thissen JT; Marnela KM
    Acta Neurol Scand; 1989 Jul; 80(1):6-11. PubMed ID: 2476907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotransmitter metabolites in medicated epileptic patients.
    Markianos M; Kalfakis N
    Funct Neurol; 1991; 6(4):367-70. PubMed ID: 1725777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD; Sourkes TL; Fang TY; Young SN; Gauthier SG; Missala K
    Neurology; 1979 Aug; 29(8):1157-61. PubMed ID: 37460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF levels of neurotransmitters in Alzheimer-type dementia. Effects of ergoloid mesylate.
    Seeldrayers P; Messina D; Desmedt D; Dalesio O; Hildebrand J
    Acta Neurol Scand; 1985 May; 71(5):411-4. PubMed ID: 2409733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotransmitter metabolites in CSF: an external quality control scheme.
    Bräutigam C; Weykamp C; Hoffmann GF; Wevers RA
    J Inherit Metab Dis; 2002 Aug; 25(4):287-98. PubMed ID: 12227459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The changes of monoamine metabolites in CSF of patients with cerebral stroke].
    Tang HZ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):130-2, 186. PubMed ID: 1716195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biogenic amine metabolites and thiamine in cerebrospinal fluid in heredo-degenerative ataxias.
    Botez MI; Young SN
    Can J Neurol Sci; 2001 May; 28(2):134-40. PubMed ID: 11383938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular CSF of comatose patients with obstructive hydrocephalus.
    Inagawa T; Ishikawa S; Uozumi T
    J Neurosurg; 1980 May; 52(5):635-41. PubMed ID: 6154788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
    Langlais PJ; Walsh FX; Bird ED; Levy HL
    Pediatrics; 1985 Mar; 75(3):580-6. PubMed ID: 2579365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis.
    Markianos M; Koutsis G; Evangelopoulos ME; Mandellos D; Karahalios G; Sfagos C
    J Neurochem; 2009 Jan; 108(1):158-64. PubMed ID: 19014375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid amine metabolites in acute schizophrenia.
    Post RM; Fink E; Carpenter WT; Goodwin FK
    Arch Gen Psychiatry; 1975 Aug; 32(8):1063-9. PubMed ID: 1156113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF neurotransmitter metabolites and neuropsychiatric symptomatology in patients with normal pressure hydrocephalus.
    Markianos M; Lafazanos S; Koutsis G; Sfagos C; Seretis A
    Clin Neurol Neurosurg; 2009 Apr; 111(3):231-4. PubMed ID: 19046799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.